bpi-16350
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jan 31, 2019 (NCT03791112)
Timeline
Indications
Mechanism of action
- Cyclin-dependent kinase 6INHIBITOR
CDK6 inhibitor
- Cyclin-dependent kinase 4INHIBITOR
CDK4 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05433480 | Phase 3 | Jun 30, 2022 | Betta Pharmaceuticals Co.,Ltd., Fudan University, Sun Yat-Sen University |
| NCT05316259 | Phase 1 | Apr 22, 2022 | Betta Pharmaceuticals Co.,Ltd., Capital Medical University |
| NCT03791112 | Phase 1 | Jan 31, 2019 | Betta Pharmaceuticals Co.,Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Betta Pharmaceuticals Co.,Ltd. | For profit | 3 | 3 | 2 | 2019 |
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Fudan University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 0 | 1 | 2022 |
4 organizations
Page 1 / 1